Fish oil may help kids survive stem cell transplants with fewer side effects

NCT ID NCT02512718

Completed Disease control Sponsor: Alexandra N. Carey Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-stage trial tested whether a fish oil fat emulsion is safe for children undergoing stem cell transplants for cancer or blood disorders. Twenty children received either fish oil or standard soybean oil fat emulsion through an IV. The goal was to see if fish oil could reduce infections and other complications, but this small study only looked at safety, not effectiveness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fish oil lipid emulsion (Omegaven)
What this could lead to: If safe, this could pave the way for a larger study to see if fish oil reduces infections and side effects in children after stem cell transplants.
What could go wrong: This is a very early, small Phase 1 safety trial with only 20 children. It is not designed to prove effectiveness, and results may not lead to any change in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC STEM CELL TRANSPLANTATION

Contacts and locations

Locations

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.